Discussion
ADHD
Clinical studies utilize The onset of time of clinical effect was defined as the earliest time point at which the difference between placebo and AMPH EROS response was statistically significant. The onset of response was the same for all clinical scores assessed. The larger effect size was noted for SKAMP-C indicating that this clinical score was most sensitive to treatment with AMPH EROS. All scores reached statistical significance within 1 hour postdose, a result confirmed by an exploratory analysis of time to onset of AMPH EROS, which showed onset at 30 minutes postdose in a population of 18 subjects (Childress et al, Meta-analyses to measure the effect size for efficacy of stimulants based on performance measurements in the patient's environment, have found amphetamines, as a class, to range from medium to large effects (0.85–1.19) for the treatment of ADHD in children and adolescents (Cortese et al, This study should be evaluated in the context of some limitations. First, as these are In summary, ADHD symptoms can affect aspects of life outside of school and work, such as socializing, driving, doing homework, and functioning in the family environment. Therefore, there is a need for medication that can treat patients throughout the day (Faraone et al, 